These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome. Karch H Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654 [TBL] [Abstract][Full Text] [Related]
6. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. Takahashi K; Funata N; Ikuta F; Sato S J Neuroinflammation; 2008 Mar; 5():11. PubMed ID: 18355415 [TBL] [Abstract][Full Text] [Related]
7. Induction by sphingomyelinase of shiga toxin receptor and shiga toxin 2 sensitivity in human microvascular endothelial cells. Obrig TG; Seaner RM; Bentz M; Lingwood CA; Boyd B; Smith A; Narrow W Infect Immun; 2003 Feb; 71(2):845-9. PubMed ID: 12540565 [TBL] [Abstract][Full Text] [Related]
8. Shiga Toxins: An Update on Host Factors and Biomedical Applications. Liu Y; Tian S; Thaker H; Dong M Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803852 [TBL] [Abstract][Full Text] [Related]
9. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Müthing J; Schweppe CH; Karch H; Friedrich AW Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807 [TBL] [Abstract][Full Text] [Related]
10. Pathogenic functions and diagnostic utility of cytokines/chemokines in EHEC-HUS. Shimizu M Pediatr Int; 2020 Mar; 62(3):308-315. PubMed ID: 31742829 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300 [TBL] [Abstract][Full Text] [Related]
14. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome. Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707 [TBL] [Abstract][Full Text] [Related]
15. Recent Advancements in Technologies to Detect Enterohaemorrhagic Kim J; Lee JB; Park J; Koo C; Lee MS J Microbiol Biotechnol; 2023 May; 33(5):559-573. PubMed ID: 36859335 [TBL] [Abstract][Full Text] [Related]
16. Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature. Bauwens A; Betz J; Meisen I; Kemper B; Karch H; Müthing J Cell Mol Life Sci; 2013 Feb; 70(3):425-57. PubMed ID: 22766973 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli. Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800 [TBL] [Abstract][Full Text] [Related]
18. Shiga toxin-glycosphingolipid interaction: Status quo of research with focus on primary human brain and kidney endothelial cells. Legros N; Pohlentz G; Steil D; Müthing J Int J Med Microbiol; 2018 Dec; 308(8):1073-1084. PubMed ID: 30224239 [TBL] [Abstract][Full Text] [Related]
19. Receptor affinity, stability and binding mode of Shiga toxins are determinants of toxicity. Shimizu T; Sato T; Kawakami S; Ohta T; Noda M; Hamabata T Microb Pathog; 2007; 43(2-3):88-95. PubMed ID: 17532600 [TBL] [Abstract][Full Text] [Related]
20. Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells. Ehrlenbach S; Rosales A; Posch W; Wilflingseder D; Hermann M; Brockmeyer J; Karch H; Satchell SC; Würzner R; Orth-Höller D Infect Immun; 2013 Aug; 81(8):2678-85. PubMed ID: 23690395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]